Insiders iTeos Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
17.44 ^USD	+43.07%		+49.57%	+59.27%

05-10	Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains Outperform Rating	MT
05-10	ITeos Therapeutics Q1 Net Loss Widens; Initiates $120 Million Registered Direct Offering -- Shares Jump	MT

ITeos Therapeutics, Inc. Appoints Jill DeSimone to its Board of Directors, Effective March 7, 2024	03-06	CI
Iteos Therapeutics, Inc. Announces Board Changes	12-07	CI
ITeos Therapeutics, Inc. Announces Resignation of Joanne Jenkins Lager as Chief Medical Officer	26/06/23	CI
ITeos Therapeutics, Inc. Announces Resignation of Detlev Biniszkiewicz as Member of the Board of Directors	20/06/23	CI
ITeos Therapeutics, Inc. Announces Resignation of Matthew Roden from the Board	03/02/23	CI
Insider Sell: Iteos Therapeutics	12/05/22	MT
Insider Sell: iTeos Therapeutics	03/05/22	MT
Insider Buy: iTeos Therapeutics	25/03/22	MT
ITeos Therapeutics, Inc. Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer	10/01/22	CI
Insider Sell: Iteos Therapeutics	07/01/22	MT
Insider Sell: Iteos Therapeutics	06/01/22	MT
Insider Sell: Iteos Therapeutics	08/12/21	MT
Insider Sell: Iteos Therapeutics	03/12/21	MT
Insider Sell: Iteos Therapeutics	26/11/21	MT
Insider Sell: Iteos Therapeutics	18/10/21	MT
Insider Sell: Iteos Therapeutics	14/10/21	MT
Insider Sell: Iteos Therapeutics	12/10/21	MT
Insider Sell: Iteos Therapeutics	05/10/21	MT
Insider Sell: Iteos Therapeutics	28/09/21	MT
Insider Sell: Iteos Therapeutics	23/09/21	MT

No results for this search